Increased gemcitabine sensitivity in GR cells using a different IGF1R inhibitor, picropodophyllin which inhibited cell viability in the pancreatic cancer cells (Fig. S3a). This evidence concerns the gene IGF1R and familial pancreatic carcinoma.